Annual report pursuant to Section 13 and 15(d)

Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)

v2.4.0.8
Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2013
Tables/Schedules  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

 

 

December 31,

 

2013

2012

 

 

 

Convertible notes

18,900,000

18,900,000

Convertible preferred stock - Series B

11,818,181

-

Warrants

2,000,000

1,708,184

Compensation-based stock options and warrants

69,375,311

54,860,000

 

102,093,492

75,468,184